Stem cell therapy for Oteoporosis

Stem cell medical care for pathology might doubtless cut back the susceptibleness of fractures and augment lost mineral density by either increasing the numbers or restoring the operate of resident stem cells which will proliferate and differentiate into bone-forming cells. Such pathology therapies are often administrated by exogenous introduction of mesenchymal stem cells (MSCs), generally procured from bone marrow, adipose, and funiculus blood tissues or through treatments with medication or tiny molecules that recruit endogenous stem cells to osteoporotic sites